Vifor Uriach Pharma

Uriach and Galénica forge a strategic alliance to create the Vifor Uriach Pharma joint venture, a partnership that will give a boost to the marketing of existing products and help prepare future launches in the Spanish hospital market, focusing on iron replacement therapies.

The Swiss company Galénica will buy 100% of the capital of Vifor Uriach Pharma in 2012.